IGAS

This page shows the latest IGAS news and features for those working in and with pharma, biotech and healthcare.

Tremfya heads for filing in psoriatic arthritis

DAS-28 CRP), improvement in physical function (HAQ-DI), skin clearance (IGA), and quality of life (SF-36 PCS and MCS).

Swedish biotech Calliditas signs China licensing deal for autoimmune candidate

Nefecon is a novel oral formulation of the corticosteroid budesonide which targets the active ingredient to B cells in the lower small intestine and control the output of IgA antibodies. ... Calliditas has one competitor in the field, Omeros, which is
Daily Brief: Karuna raises $42m for novel CNS approach, Chen exits Roche, Orchard gains GSK board member

Immunoglobulins, also known as antibodies, comprise a family of proteins that occur in five major forms: IgM, IgD, IgG, IgE and IgA.
Morning brief: Sanofi's shaky start, pharma begins talks with UK government and more

This is the second breakthrough therapy drug designation for OMS721, which gained the status last year for treatment of Immunoglobulin A (IgA) nephropathy, in which pivotal phase III trials recently begun.
Rigel and Ultragenyx claim approvals for rare drugs

Rigel is also developing it for additional indications, including autoimmune haemolytic anaemia and IgA nephropathy.
Rigel shaken after fostamatinib misses phase III trial target

Estimates for peak sales are in the $300m-400m range. Fostamatinib is also in phase II trials for two other rare diseases - autoimmune haemolytic anaemia and IgA nephropathy.

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

New hires at Nanoform, Leo Pharma and Calliditas

IgA nephropathy (IgAN) – also known as Berger’s disease. ... Currently, there are no approved treatments for IgA Nephropathy, and Nefecon has the potential to be a disease-modifying treatment for patients suffering from this chronic autoimmune disease

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Hayward Medical Communications launch a new, eye-opening journal

Hayward is particularly pleased that the journal features regular columns from the International Glaucoma Association (IGA) and the Royal National Institute of Blind People (RNIB). .

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...: Excellent Daily Rate

Account Director - Medical Communications - London / South East: Excellent Salary and Benefits on offer

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Add my company

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

The relevance of patient perspectives to value: Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
The evolution of real-world studies: How industry and regulators are using real-world data...